Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Nurexone Biologic Inc

NRX
0,62
0,06 (10,71%)
13 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: TSX Venture
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
27/2/202522:03GLOBENurExone Biologic to Present at MIXiii 2025; Professor..
19/2/202522:03GLOBENurExone Biologic Recognized as a 2025 TSX Venture 50™ Top..
14/2/202522:03GLOBENurExone Biologic Continues Expansion of U.S. Presence and..
05/2/202522:04GLOBENurExone Forms Exo-Top Inc. in the U.S. for Exosome..
21/1/202522:20GLOBENurExone Secures C$1.2 Million through Warrant Exercises and..
08/1/202522:12GLOBENurExone Biologic Secures Master Cell Bank
06/12/202422:03GLOBENurExone Announces Promising Preclinical Results in..
27/11/202413:01GLOBENurExone Reports Third Quarter 2024 Financial Results and..
13/11/202422:14GLOBENurExone Biologic Secures EMA Orphan Status for ExoPTEN in..
01/11/202421:50GLOBENurExone Biologic Closes Final Tranche of Non-Brokered..
23/10/202408:56GLOBENurExone’s Regenerative Medicine Therapies To Be Recognized..
26/9/202422:03GLOBENurExone Biologic Announces Private Placement of up to $2M..
12/9/202422:04GLOBENurExone Biologic Extends Global Reach with Presentations at..
06/9/202422:03GLOBENurExone Demonstrates Extended Therapeutic Window of ExoPTEN..
28/8/202414:34GLOBENurExone Reports Second Quarter 2024 Financial Results and..
23/8/202422:03GLOBENurExone Biologic Invited to Present Groundbreaking ExoPTEN..
15/8/202422:03GLOBENurExone Biologic Achieves Key Milestone in Support of..
09/8/202422:04GLOBENurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability..
01/8/202422:04GLOBENurExone Announces the Transfer of Manufacturing of the..
17/7/202422:14GLOBEPromising Preliminary Results in Optic Nerve Recovery Study..
05/7/202414:43GLOBEUpdates from NurExone: Growth Conference Presentation and..
28/6/202422:04GLOBENurExone’s ExoPTEN Being Studied as Glaucoma Treatment for..
21/6/202422:04GLOBEOn Path to First-in-Human Study, NurExone Engages Prominent..
11/6/202414:44GLOBENurExone Announces Expansion of ExoPTEN Patent Coverage with..
04/6/202422:40GLOBENurExone Announces Voting Results from 2024 Annual Meeting..
29/5/202414:35GLOBENurExone Reports First Quarter 2024 Financial Results and..
17/5/202422:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
25/4/202417:30APSShares of Biopharma Up After News of Uplisting
25/4/202414:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
19/4/202422:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
02/4/202414:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
27/3/202422:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
22/3/202422:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
15/3/202421:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
Apertura: 0,59 Min: 0,59 Max: 0,65
Chiusura: 0,56

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network